Status:
UNKNOWN
Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Collaborating Sponsors:
Major Science and Technology Special Project of China Eleventh Five-year
Conditions:
Chronic Hepatitis B
Inadequate Response
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the long-term efficacy and safety of entecavir 1.0 mg/d + adefovir 10 mg/d with entecavir 0.5 mg/d + adefovir 10 mg/d for chronic hepatitis B patients with inad...
Eligibility Criteria
Inclusion
- Subjects who completed the 104-week Dragon study.
- Subjects who are willing to participate the extension study.
Exclusion
- Subjects who could not compliance with the protocol judged by investigators
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT01829685
Start Date
March 1 2013
Last Update
June 19 2014
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Ditan Hospital
Beijing, Beijing Municipality, China
2
Beijing Friendship Hospital Attached To The Capital Medical University
Beijing, Beijing Municipality, China
3
Department of infectious disease, First Hospital of Peking University
Beijing, Beijing Municipality, China
4
People's Hospital Under Beijnig University
Beijing, Beijing Municipality, China